Nuvation Bio's fundamentals hinge on Ibtrozi (taletrectinib), a next-gen ROS1 inhibitor now commercial. Read why I rate NUVB ...

Climb Bio Inc. CLYM on Thursday shared initial data from its ongoing Phase 1b portion of its Phase 1b/2a study of budoprutug ...

KRRO-110 miss drives overhaul; KRRO-121/111 show preclinical promise. Click here to read my most recent analysis of the stock ...

Shares of Nuvation Bio (NYSE: NUVB) were skyrocketing 15.7% higher as of 11:20 a.m. ET on Tuesday. The big jump came after two positive developments for the cancer-focused drugmaker. Which news ...

Bluebird Bio has three approved gene-editing therapies: Zynteglo, Skysona, and Lyfgenia. The most important of this trio, and the latest to earn approval (it did so in December), is Lyfgenia, which ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

View Bio-Rad Laboratories, Inc. Class A BIO stock quote prices, financial information, real-time forecasts, and company news from CNN.

On Thursday, Tevogen Bio Holdings Inc. (NASDAQ:TVGN) announced its top-line revenue forecast for its oncology pipeline, projecting $1 billion in revenue in its launch year and a cumulative 5-year ...